Search research articles
Contact Us
Filters
Showing results (91-100 of 188) with videos related to
Page
of 19
Sort By:
Ejhaem
|
October 17, 2024
Successful management with urgent haploidentical-peripheral blood stem cell transplantation for a patient with severe aplastic anaemia who developed disseminated fungal infection following immunosuppressive therapy
Norihito Ikenobe, Kentaro Fujimori, Yoshihiro Gocho, et al.
Pediatric Blood & Cancer
|
September 29, 2020
The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study
Hiroshi Moritake, Shiro Tanaka, Takako Miyamura, et al.
British Journal of Haematology
|
October 16, 2019
Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup
Yusuke Hara, Norio Shiba, Genki Yamato, et al.
British Journal of Haematology
|
July 22, 2014
Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group
Akitoshi Kinoshita, Hayato Miyachi, Hiromichi Matsushita, et al.
British Journal of Haematology
|
December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial
Norio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
Pediatric Blood & Cancer
|
July 2, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial
Masahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, et al.
British Journal of Haematology
|
February 21, 2019
Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study
Takako Miyamura, Hiroshi Moritake, Hideki Nakayama, et al.
Pediatric Blood & Cancer
|
May 3, 2016
CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group
Hidemasa Matsuo, Naomi Nakamura, Daisuke Tomizawa, et al.
Pediatric Blood & Cancer
|
August 5, 2024
Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan
Shota Kato, Kentaro Nakashima, Genki Yamato, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 15, 2015
Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation
Hiroyuki Ishida, Motohiro Kato, Kazuko Kudo, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 188) with videos related to
Sort By:
Page
of 19
Ejhaem
|
October 17, 2024
Successful management with urgent haploidentical-peripheral blood stem cell transplantation for a patient with severe aplastic anaemia who developed disseminated fungal infection following immunosuppressive therapy
Norihito Ikenobe, Kentaro Fujimori, Yoshihiro Gocho, et al.
Pediatric Blood & Cancer
|
September 29, 2020
The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study
Hiroshi Moritake, Shiro Tanaka, Takako Miyamura, et al.
British Journal of Haematology
|
October 16, 2019
Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup
Yusuke Hara, Norio Shiba, Genki Yamato, et al.
British Journal of Haematology
|
July 22, 2014
Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group
Akitoshi Kinoshita, Hayato Miyachi, Hiromichi Matsushita, et al.
British Journal of Haematology
|
December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial
Norio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
Pediatric Blood & Cancer
|
July 2, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial
Masahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, et al.
British Journal of Haematology
|
February 21, 2019
Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study
Takako Miyamura, Hiroshi Moritake, Hideki Nakayama, et al.
Pediatric Blood & Cancer
|
May 3, 2016
CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group
Hidemasa Matsuo, Naomi Nakamura, Daisuke Tomizawa, et al.
Pediatric Blood & Cancer
|
August 5, 2024
Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan
Shota Kato, Kentaro Nakashima, Genki Yamato, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 15, 2015
Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation
Hiroyuki Ishida, Motohiro Kato, Kazuko Kudo, et al.
Page
of 19